The global market for Small Molecule Nucleic Acid Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Small Molecule Nucleic Acid Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Small Molecule Nucleic Acid Drug by region & country, by Type, and by Application.

The Small Molecule Nucleic Acid Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Nucleic Acid Drug.

Market Segmentation

Scope of Small Molecule Nucleic Acid Drug - Market Report

Report Metric	Details
Report Name	Small Molecule Nucleic Acid Drug - Market
CAGR	5%
Segment by Type:	Antisense Nucleic Acid (ASO) Small Interfering Nucleic Acid (siRNA) MicroRNA (miRNA) Nucleic Acid Aptamer (Aptamer) Transfer RNA (tRNA) Fragmentation
Segment by Application	Hospital Specialty Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Pfizer, Jazz, Sarepta Therapeutics, Alnylam, Novartis, Nippon Shinyaku, Swedish Orphan Biovitrum
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Small Molecule Nucleic Acid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Small Molecule Nucleic Acid Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Small Molecule Nucleic Acid Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Small Molecule Nucleic Acid Drug - Market report?

Ans: The main players in the Small Molecule Nucleic Acid Drug - Market are Biogen, Pfizer, Jazz, Sarepta Therapeutics, Alnylam, Novartis, Nippon Shinyaku, Swedish Orphan Biovitrum

What are the Application segmentation covered in the Small Molecule Nucleic Acid Drug - Market report?

Ans: The Applications covered in the Small Molecule Nucleic Acid Drug - Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Small Molecule Nucleic Acid Drug - Market report?

Ans: The Types covered in the Small Molecule Nucleic Acid Drug - Market report are Antisense Nucleic Acid (ASO), Small Interfering Nucleic Acid (siRNA), MicroRNA (miRNA), Nucleic Acid Aptamer (Aptamer), Transfer RNA (tRNA) Fragmentation

1 Market Overview

1.1 Small Molecule Nucleic Acid Drug Product Introduction

1.2 Global Small Molecule Nucleic Acid Drug Market Size Forecast

1.2.1 Global Small Molecule Nucleic Acid Drug Sales Value (2019-2030)

1.2.2 Global Small Molecule Nucleic Acid Drug Sales Volume (2019-2030)

1.2.3 Global Small Molecule Nucleic Acid Drug Sales Price (2019-2030)

1.3 Small Molecule Nucleic Acid Drug Market Trends & Drivers

1.3.1 Small Molecule Nucleic Acid Drug Industry Trends

1.3.2 Small Molecule Nucleic Acid Drug Market Drivers & Opportunity

1.3.3 Small Molecule Nucleic Acid Drug Market Challenges

1.3.4 Small Molecule Nucleic Acid Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Small Molecule Nucleic Acid Drug Players Revenue Ranking (2023)

2.2 Global Small Molecule Nucleic Acid Drug Revenue by Company (2019-2024)

2.3 Global Small Molecule Nucleic Acid Drug Players Sales Volume Ranking (2023)

2.4 Global Small Molecule Nucleic Acid Drug Sales Volume by Company Players (2019-2024)

2.5 Global Small Molecule Nucleic Acid Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Small Molecule Nucleic Acid Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Small Molecule Nucleic Acid Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Small Molecule Nucleic Acid Drug

2.9 Small Molecule Nucleic Acid Drug Market Competitive Analysis

2.9.1 Small Molecule Nucleic Acid Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Small Molecule Nucleic Acid Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Nucleic Acid Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antisense Nucleic Acid (ASO)

3.1.2 Small Interfering Nucleic Acid (siRNA)

3.1.3 MicroRNA (miRNA)

3.1.4 Nucleic Acid Aptamer (Aptamer)

3.1.5 Transfer RNA (tRNA) Fragmentation

3.2 Global Small Molecule Nucleic Acid Drug Sales Value by Type

3.2.1 Global Small Molecule Nucleic Acid Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Small Molecule Nucleic Acid Drug Sales Value, by Type (2019-2030)

3.2.3 Global Small Molecule Nucleic Acid Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Small Molecule Nucleic Acid Drug Sales Volume by Type

3.3.1 Global Small Molecule Nucleic Acid Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Small Molecule Nucleic Acid Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Small Molecule Nucleic Acid Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Small Molecule Nucleic Acid Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Specialty Clinic

4.1.3 Others

4.2 Global Small Molecule Nucleic Acid Drug Sales Value by Application

4.2.1 Global Small Molecule Nucleic Acid Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Small Molecule Nucleic Acid Drug Sales Value, by Application (2019-2030)

4.2.3 Global Small Molecule Nucleic Acid Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Small Molecule Nucleic Acid Drug Sales Volume by Application

4.3.1 Global Small Molecule Nucleic Acid Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Small Molecule Nucleic Acid Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Small Molecule Nucleic Acid Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Small Molecule Nucleic Acid Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Small Molecule Nucleic Acid Drug Sales Value by Region

5.1.1 Global Small Molecule Nucleic Acid Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Small Molecule Nucleic Acid Drug Sales Value by Region (2019-2024)

5.1.3 Global Small Molecule Nucleic Acid Drug Sales Value by Region (2025-2030)

5.1.4 Global Small Molecule Nucleic Acid Drug Sales Value by Region (%), (2019-2030)

5.2 Global Small Molecule Nucleic Acid Drug Sales Volume by Region

5.2.1 Global Small Molecule Nucleic Acid Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Small Molecule Nucleic Acid Drug Sales Volume by Region (2019-2024)

5.2.3 Global Small Molecule Nucleic Acid Drug Sales Volume by Region (2025-2030)

5.2.4 Global Small Molecule Nucleic Acid Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Small Molecule Nucleic Acid Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

5.4.2 North America Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

5.5.2 Europe Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

5.7.2 South America Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value

6.2.1 Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.3.2 United States Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.4.2 Europe Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.5.2 China Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.6.2 Japan Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.7.2 South Korea Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Small Molecule Nucleic Acid Drug Sales Value, 2019-2030

6.9.2 India Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Small Molecule Nucleic Acid Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Biogen

7.1.1 Biogen Company Information

7.1.2 Biogen Introduction and Business Overview

7.1.3 Biogen Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Biogen Small Molecule Nucleic Acid Drug Product Offerings

7.1.5 Biogen Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Small Molecule Nucleic Acid Drug Product Offerings

7.2.5 Pfizer Recent Development

7.3 Jazz

7.3.1 Jazz Company Information

7.3.2 Jazz Introduction and Business Overview

7.3.3 Jazz Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Jazz Small Molecule Nucleic Acid Drug Product Offerings

7.3.5 Jazz Recent Development

7.4 Sarepta Therapeutics

7.4.1 Sarepta Therapeutics Company Information

7.4.2 Sarepta Therapeutics Introduction and Business Overview

7.4.3 Sarepta Therapeutics Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sarepta Therapeutics Small Molecule Nucleic Acid Drug Product Offerings

7.4.5 Sarepta Therapeutics Recent Development

7.5 Alnylam

7.5.1 Alnylam Company Information

7.5.2 Alnylam Introduction and Business Overview

7.5.3 Alnylam Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Alnylam Small Molecule Nucleic Acid Drug Product Offerings

7.5.5 Alnylam Recent Development

7.6 Novartis

7.6.1 Novartis Company Information

7.6.2 Novartis Introduction and Business Overview

7.6.3 Novartis Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Novartis Small Molecule Nucleic Acid Drug Product Offerings

7.6.5 Novartis Recent Development

7.7 Nippon Shinyaku

7.7.1 Nippon Shinyaku Company Information

7.7.2 Nippon Shinyaku Introduction and Business Overview

7.7.3 Nippon Shinyaku Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Nippon Shinyaku Small Molecule Nucleic Acid Drug Product Offerings

7.7.5 Nippon Shinyaku Recent Development

7.8 Swedish Orphan Biovitrum

7.8.1 Swedish Orphan Biovitrum Company Information

7.8.2 Swedish Orphan Biovitrum Introduction and Business Overview

7.8.3 Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Product Offerings

7.8.5 Swedish Orphan Biovitrum Recent Development

8 Industry Chain Analysis

8.1 Small Molecule Nucleic Acid Drug Industrial Chain

8.2 Small Molecule Nucleic Acid Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Small Molecule Nucleic Acid Drug Sales Model

8.5.2 Sales Channel

8.5.3 Small Molecule Nucleic Acid Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Swedish Orphan Biovitrum

List of Tables

Table 1. Small Molecule Nucleic Acid Drug Market Trends

Table 2. Small Molecule Nucleic Acid Drug Market Drivers & Opportunity

Table 3. Small Molecule Nucleic Acid Drug Market Challenges

Table 4. Small Molecule Nucleic Acid Drug Market Restraints

Table 5. Global Small Molecule Nucleic Acid Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Small Molecule Nucleic Acid Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Small Molecule Nucleic Acid Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Small Molecule Nucleic Acid Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Small Molecule Nucleic Acid Drug Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Small Molecule Nucleic Acid Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Small Molecule Nucleic Acid Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Small Molecule Nucleic Acid Drug

Table 13. Global Small Molecule Nucleic Acid Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Nucleic Acid Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Small Molecule Nucleic Acid Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Small Molecule Nucleic Acid Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Small Molecule Nucleic Acid Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Small Molecule Nucleic Acid Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Small Molecule Nucleic Acid Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Small Molecule Nucleic Acid Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Small Molecule Nucleic Acid Drug Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Small Molecule Nucleic Acid Drug Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Small Molecule Nucleic Acid Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Small Molecule Nucleic Acid Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Small Molecule Nucleic Acid Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Small Molecule Nucleic Acid Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Small Molecule Nucleic Acid Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Small Molecule Nucleic Acid Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Small Molecule Nucleic Acid Drug Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Small Molecule Nucleic Acid Drug Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Small Molecule Nucleic Acid Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Small Molecule Nucleic Acid Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Small Molecule Nucleic Acid Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Small Molecule Nucleic Acid Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Small Molecule Nucleic Acid Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Small Molecule Nucleic Acid Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Small Molecule Nucleic Acid Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Small Molecule Nucleic Acid Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Small Molecule Nucleic Acid Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Small Molecule Nucleic Acid Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Small Molecule Nucleic Acid Drug Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Small Molecule Nucleic Acid Drug Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Biogen Company Information

Table 58. Biogen Introduction and Business Overview

Table 59. Biogen Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Biogen Small Molecule Nucleic Acid Drug Product Offerings

Table 61. Biogen Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Pfizer Small Molecule Nucleic Acid Drug Product Offerings

Table 66. Pfizer Recent Development

Table 67. Jazz Company Information

Table 68. Jazz Introduction and Business Overview

Table 69. Jazz Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Jazz Small Molecule Nucleic Acid Drug Product Offerings

Table 71. Jazz Recent Development

Table 72. Sarepta Therapeutics Company Information

Table 73. Sarepta Therapeutics Introduction and Business Overview

Table 74. Sarepta Therapeutics Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Sarepta Therapeutics Small Molecule Nucleic Acid Drug Product Offerings

Table 76. Sarepta Therapeutics Recent Development

Table 77. Alnylam Company Information

Table 78. Alnylam Introduction and Business Overview

Table 79. Alnylam Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Alnylam Small Molecule Nucleic Acid Drug Product Offerings

Table 81. Alnylam Recent Development

Table 82. Novartis Company Information

Table 83. Novartis Introduction and Business Overview

Table 84. Novartis Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Novartis Small Molecule Nucleic Acid Drug Product Offerings

Table 86. Novartis Recent Development

Table 87. Nippon Shinyaku Company Information

Table 88. Nippon Shinyaku Introduction and Business Overview

Table 89. Nippon Shinyaku Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Nippon Shinyaku Small Molecule Nucleic Acid Drug Product Offerings

Table 91. Nippon Shinyaku Recent Development

Table 92. Swedish Orphan Biovitrum Company Information

Table 93. Swedish Orphan Biovitrum Introduction and Business Overview

Table 94. Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Product Offerings

Table 96. Swedish Orphan Biovitrum Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Small Molecule Nucleic Acid Drug Downstream Customers

Table 100. Small Molecule Nucleic Acid Drug Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Small Molecule Nucleic Acid Drug Product Picture

Figure 2. Global Small Molecule Nucleic Acid Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Small Molecule Nucleic Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Small Molecule Nucleic Acid Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Small Molecule Nucleic Acid Drug Sales Price (2019-2030) & (US$/Unit)

Figure 6. Small Molecule Nucleic Acid Drug Report Years Considered

Figure 7. Global Small Molecule Nucleic Acid Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Small Molecule Nucleic Acid Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Small Molecule Nucleic Acid Drug Revenue in 2023

Figure 10. Small Molecule Nucleic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Antisense Nucleic Acid (ASO) Picture

Figure 12. Small Interfering Nucleic Acid (siRNA) Picture

Figure 13. MicroRNA (miRNA) Picture

Figure 14. Nucleic Acid Aptamer (Aptamer) Picture

Figure 15. Transfer RNA (tRNA) Fragmentation Picture

Figure 16. Global Small Molecule Nucleic Acid Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Small Molecule Nucleic Acid Drug Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Small Molecule Nucleic Acid Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Small Molecule Nucleic Acid Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Small Molecule Nucleic Acid Drug Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Hospital

Figure 22. Product Picture of Specialty Clinic

Figure 23. Product Picture of Others

Figure 24. Global Small Molecule Nucleic Acid Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Small Molecule Nucleic Acid Drug Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Small Molecule Nucleic Acid Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Small Molecule Nucleic Acid Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Small Molecule Nucleic Acid Drug Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Small Molecule Nucleic Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Small Molecule Nucleic Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Small Molecule Nucleic Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Small Molecule Nucleic Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Small Molecule Nucleic Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Small Molecule Nucleic Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Small Molecule Nucleic Acid Drug Sales Volume (%), (2019-2030)

Figure 41. United States Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. China Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. China Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 59. India Small Molecule Nucleic Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Small Molecule Nucleic Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 61. India Small Molecule Nucleic Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 62. Small Molecule Nucleic Acid Drug Industrial Chain

Figure 63. Small Molecule Nucleic Acid Drug Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions